Regulation of Myogenic Differentiation by Androgens: Cross Talk between Androgen Receptor/ β-Catenin and Follistatin/Transforming Growth Factor-β Signaling Pathways
Open Access
- 23 October 2008
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (3) , 1259-1268
- https://doi.org/10.1210/en.2008-0858
Abstract
Androgens are important regulators of body composition and promote myogenic differentiation and inhibit adipogenesis of mesenchymal, multipotent cells. Here, we investigated the mechanisms by which androgens induce myogenic differentiation of mesenchymal multipotent cells. Incubation of mesenchymal multipotent C3H 10T1/2 cells with testosterone and dihydrotestosterone promoted nuclear translocation of androgen receptor (AR)/β-catenin complex and physical interaction of AR, β-catenin, and T-cell factor-4 (TCF-4). Inhibition of β-catenin by small inhibitory RNAs significantly decreased testosterone-induced stimulation of myogenic differentiation. Overexpression of TCF-4, a molecule downstream of β-catenin in Wnt signaling cascade, in C3H 10T1/2 cells significantly up-regulated expression of myoD and myosin heavy chain II proteins and of follistatin (Fst), which binds and antagonizes native ligands of the TGF-β/Smad pathway. Gene array analysis of C3H 10T1/2 cells treated with testosterone revealed that testosterone up-regulated the expression of Fst and modified the expression of several signaling molecules involved in the TGF-β/Smad pathway, including Smad7. Lowering of testosterone levels in mice by orchidectomy led to a significant decrease in Fst and Smad7 expression; conversely, testosterone supplementation in castrated mice up-regulated Fst and Smad7 mRNA expression in androgen-responsive levator ani muscle. Testosterone-induced up-regulation of MyoD and myosin heavy chain II proteins in C3H 10T1/2 cells was abolished in cells simultaneously treated with anti-Fst antibody, suggesting an essential role of Fst during testosterone regulation of myogenic differentiation. In conclusion, our data suggest the involvement of AR, β-catenin, and TCF-4 pathway during androgen action to activate a number of Wnt target genes, including Fst, and cross communication with the Smad signaling pathway. Androgen-induced myogenic differentiation in mouse multipotent C3H 10T1/2 cells is mediated through androgen receptor/β-catenin signaling pathway to upregulate follistatin and cross-communication with TGF-β/Smad signaling pathway.Keywords
This publication has 51 references indexed in Scilit:
- Conditional deletion of β-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometriumDevelopmental Biology, 2005
- Wnt10b Deficiency Promotes Coexpression of Myogenic and Adipogenic Programs in MyoblastsMolecular Biology of the Cell, 2005
- Alterations in the TGFβ signaling pathway in myogenic progenitors with ageAging Cell, 2004
- Liganded Androgen Receptor Interaction with β-CateninJournal of Biological Chemistry, 2002
- The Androgen Receptor Can Promote β-Catenin Nuclear Translocation Independently of Adenomatous Polyposis ColiJournal of Biological Chemistry, 2002
- Inhibition of Adipogenesis by Wnt SignalingScience, 2000
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- Activin-Binding Protein from Rat Ovary Is FollistatinScience, 1990
- Transfection of a DNA locus that mediates the conversion of 10T12 fibroblasts to myoblastsCell, 1986
- Multiple new phenotypes induced in and 3T3 cells treated with 5-azacytidineCell, 1979